Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 5
1999 7
2000 4
2001 6
2002 8
2003 8
2004 10
2005 13
2006 12
2007 18
2008 16
2009 15
2010 15
2011 10
2012 11
2013 8
2014 13
2015 8
2016 6
2017 7
2018 7
2019 8
2020 10
2021 8
2022 2
2023 7
2024 10
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Xie M, Tang T, Liang H. Xie M, et al. Clin Cardiol. 2023 Aug;46(8):886-898. doi: 10.1002/clc.24082. Epub 2023 Jul 11. Clin Cardiol. 2023. PMID: 37432701 Free PMC article.
The results of the network meta-analysis showed that a total of 11 single-pill combination antihypertensive drugs were included, namely: Amlodipine/valsartan, Telmisartan/amlodipine, Losartan/HCTZ, Candesartan/HCTZ, Amlodipine/benazepril, Telmisartan/HCTZ, Valsartan/HCTZ, Irbe …
The results of the network meta-analysis showed that a total of 11 single-pill combination antihypertensive drugs were included, namely: Aml …
Drugs for hypertension.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2024 May 27;66(1703):81-88. doi: 10.58347/tml.2024.1703a. Med Lett Drugs Ther. 2024. PMID: 38771738 Review. No abstract available.
Irbesartan and hydrochlorothiazide association in the treatment of hypertension.
Derosa G, Ferrari I, Cicero AF. Derosa G, et al. Curr Vasc Pharmacol. 2009 Apr;7(2):120-36. doi: 10.2174/157016109787455644. Curr Vasc Pharmacol. 2009. PMID: 19355995 Review.
Irbesartan also induced regression of left ventricular hypertrophy. Moreover, irbesartan 300 mg/day exerts a significant renoprotective effect in hypertensive type 2 diabetic patients. ...The overall incidence of adverse events is similar to that of placebo. A fixed …
Irbesartan also induced regression of left ventricular hypertrophy. Moreover, irbesartan 300 mg/day exerts a significant renop …
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension.
Bramlage P. Bramlage P. Vasc Health Risk Manag. 2009;5(1):213-24. doi: 10.2147/vhrm.s3302. Epub 2009 Apr 8. Vasc Health Risk Manag. 2009. PMID: 19436667 Free PMC article. Review.
The efficacy and tolerability of FD irbesartan/HCTZ has been demonstrated in both patient populations in large multicenter studies. ...In patients with moderate or severe hypertension receiving FD irbesartan/HCTZ as initial therapy, this combination achieved more ra …
The efficacy and tolerability of FD irbesartan/HCTZ has been demonstrated in both patient populations in large multicenter studies. . …
Irbesartan (a comprehensive profile).
Darwish IA, Darwish HW, Bakheit AH, Al-Kahtani HM, Alanazi Z. Darwish IA, et al. Profiles Drug Subst Excip Relat Methodol. 2021;46:185-272. doi: 10.1016/bs.podrm.2020.07.004. Epub 2020 Aug 21. Profiles Drug Subst Excip Relat Methodol. 2021. PMID: 33461698 Review.
Irbesartan can be used alone or in combination with other antihypertensive agents (e.g., hydrochlorothiazide). ...Irbesartan exerts its action mainly via a selective blockade action on AT1 receptors and the consequent reduced pressor effect of angiotensin II. …
Irbesartan can be used alone or in combination with other antihypertensive agents (e.g., hydrochlorothiazide). ...Irbesarta …
Simultaneous Determination of Hydrochlorothiazide and Irbesartan from Pharmaceutical Dosage Forms with RP-HPLC.
KurbanoĞlu S, Yarman A. KurbanoĞlu S, et al. Turk J Pharm Sci. 2020 Oct;17(5):523-527. doi: 10.4274/tjps.galenos.2019.76094. Epub 2020 Oct 30. Turk J Pharm Sci. 2020. PMID: 33177933 Free PMC article.
OBJECTIVES: In this work, a simple and rapid liquid chromatographic method for the simultaneous determination of irbesartan (IRBE) and hydrochlorothiazide (HCT) was developed and validated by reverse phase high performance liquid chromatography (RP-HPLC). ...
OBJECTIVES: In this work, a simple and rapid liquid chromatographic method for the simultaneous determination of irbesartan (IRBE) an …
Drug interactions with irbesartan.
Marino MR, Vachharajani NN. Marino MR, et al. Clin Pharmacokinet. 2001;40(8):605-14. doi: 10.2165/00003088-200140080-00004. Clin Pharmacokinet. 2001. PMID: 11523726 Review.
Irbesartan is an angiotensin II receptor antagonist indicated for the treatment of patients with hypertension. ...This paper reviews the drug and food interaction trials involving irbesartan that have been conducted to date. Based on the available literature, no sig …
Irbesartan is an angiotensin II receptor antagonist indicated for the treatment of patients with hypertension. ...This paper reviews …
Drugs for hypertension.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 May 18;62(1598):73-80. Med Lett Drugs Ther. 2020. PMID: 32555118 No abstract available.
The risks and benefits of initial irbesartan/hydrochlorothiazide combination therapy in patients with severe hypertension.
Lapuerta P, Franklin S. Lapuerta P, et al. J Clin Hypertens (Greenwich). 2009 May;11(5):277-83. doi: 10.1111/j.1751-7176.2009.00109.x. J Clin Hypertens (Greenwich). 2009. PMID: 19534037 Free PMC article. Review.
Combination therapies may hold promise as initial treatment for these patients. The safety and efficacy of initial irbesartan / hydrochlorothiazide (angiotensin receptor blocker / thiazide) treatment was compared with that of irbesartan as monotherapy in a mu …
Combination therapies may hold promise as initial treatment for these patients. The safety and efficacy of initial irbesartan / hy …
Effect of administration of low-dose irbesartan and hydrochlorothiazide combined with levamlodipine at different times on the circadian rhythm of blood pressure and the levels of MMPs and TIMPs in non-dipper patients with grade 1 and 2 hypertension.
Yan P, Luo Y, Zhang J, Liu H, Chen J, Wang J, Dong G, Ge M. Yan P, et al. J Clin Hypertens (Greenwich). 2023 Feb;25(2):137-145. doi: 10.1111/jch.14630. Epub 2023 Jan 14. J Clin Hypertens (Greenwich). 2023. PMID: 36639984 Free PMC article. Clinical Trial.
This study aimed to probe the effects of low-dose irbesartan and hydrochlorothiazide in combination with levamlodipine at different times on the circadian rhythm of blood pressure, matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases (TIMPs) …
This study aimed to probe the effects of low-dose irbesartan and hydrochlorothiazide in combination with levamlodipine at diff …
236 results